Arcadia Biosciences, Inc. — Director's Dealing 2015

Nov 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-11-11

Reporting Person: Knauf Vic C. (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-11	Common Stock	M	20000	$0.44	Acquired	51661	Direct
2015-11-11	Common Stock	S	4527	$2.9138	Disposed	47134	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-11	Employee Stock Option (right to buy)	$0.44	M	20000	Disposed	2015-12-31	Common Stock (20000)	Direct

Footnotes

F1: The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015.

F2: This transaction was executed in multiple trades at prices ranging from $2.82 to $2.9224. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: The option is fully exercisable as of the date hereof.